The best treat­ment for breast can­cer is che­mother­apy.

Shape (Singapore) - - Live Healthy -

BREAK IT DOWN: More women with breast can­cer can skip this once-stan­dard treat­ment, ac­cord­ing to a new study. “Un­til now, we’ve known that women with hor­mon­ally driven breast can­cer who are clas­si­fied as low-risk didn’t need che­mother­apy, while women who were high-risk did. We weren’t sure about the in­ter­me­di­ates. But a new trial called TAILORx found that most in­ter­me­di­ates also got no sig­nif­i­cant ben­e­fit from che­mother­apy,” Dr Hamil­ton shares. “The re­sults will likely save 60,000 pa­tients a year from re­ceiv­ing chemo.” That means avoid­ing many side ef­fects, such as dam­age to heart and lung cells, hair loss and nau­sea. It’s a big win for per­son­alised medicine, she says. “We’re con­stantly de­vel­op­ing new ther­a­pies, and now we’re get­ting bet­ter at de­ter­min­ing who needs exactly which treat­ments.”

Newspapers in English

Newspapers from Singapore

© PressReader. All rights reserved.